What Should Investors Do With the New Wave of IPOs?
Most important take away
The hosts uniformly recommend not buying hyped AI-adjacent IPOs on day one. With Cerebras pricing at ~$50B (a ~6x markup from its September Series G) and demand 20x oversubscribed, the consensus is to wait for the hype to settle, watch execution on the new OpenAI/AWS contracts, and ideally buy a starter position with fresh capital rather than trimming winners — both because of taxes and because recent AI IPOs (Figma, Klarna, StubHub) have generally underperformed once the hype faded.
Summary
Stocks and investments mentioned
Monday.com (MNDY) — covered after a Q4 earnings beat that sent shares up ~25% pre-market (though paring gains as recording continued). Stock is still down ~50% YTD and ~70% over the past year.
Key numbers:
- Revenue $351M, +24% YoY (beat expectations)
- Adjusted EPS $1.15 (vs. 93¢ guided)
- Raised 2026 guidance to ~$1.5B in revenue
- Net dollar retention 110%
- RPO (remaining performance obligations) up 33% YoY — future booked work growing faster than current revenue
- $100K+ ARR customers up 39% YoY
- AI drove 10% of new ARR
- New “seats + credits” pricing model just announced
- Operating margin doubled from 3% → 6% YoY
- Headcount expected to stay stable next year
Actionable take: Matt is not a buyer but it’s on his radar (large buybacks, narrative reframed from “AI victim” to “AI tailwind”). Rachel notes stock-based compensation and lack of GAAP profitability keep pressure on the shares. Top-line growth is still decelerating (25% → 24% → 18–19% guided), so the core “approaching ceiling” thesis remains intact. Recommendation: watch but don’t chase.
Cerebras (upcoming IPO, possibly this week) — wafer-scale AI chip company positioning as an Nvidia alternative.
Key facts:
- Raising ~$5B at a ~$50B valuation
- IPO range raised to $150–$160/share
- Demand 20x oversubscribed
- Valuation up ~6x from September’s $8B Series G
- Revenue grew 76% YoY in 2025
- 47% GAAP net margin last year
- Valuation: ~100x sales
- CS3 inference reportedly 21x faster than Nvidia’s flagship GPU at 32% lower total cost
- Recent deals: AWS binding term sheet (March), OpenAI deal
- Customer concentration risk: 86% of 2025 revenue from two UAE-affiliated entities (G42 and Mohamed bin Zayed University of AI)
Bull case: unique wafer-scale architecture, well positioned for the inference/agentic AI wave (where Nvidia’s training advantage matters less), big-name customer wins are diversifying the base.
Bear case: extreme customer concentration, ~100x sales valuation prices in perfect execution, Nvidia’s effectively unlimited R&D budget can erode the moat, no GAAP profitability, generally turbulent track record of recent AI IPOs.
Actionable recommendation from both hosts: do not buy at IPO. Matt: “I’ll almost never buy an IPO stock on day one… I don’t see myself buying Cerebras on days two, three or four either.” What would change their minds — a more reasonable valuation, demonstrated revenue diversification away from G42/MBZUAI, and continued growth as the AWS and OpenAI contracts convert from backlog to recognized revenue.
Other IPOs referenced as cautionary examples: Figma, Klarna (Carna in transcript), StubHub — all hyped, all “turbulent at best,” with most underperforming. Pattern: better to wait for hype to subside before initiating.
Companies the listener question mentioned: Anthropic, OpenAI, SpaceX (pre-IPO, owned via secondaries/funds).
Actionable insights on IPO strategy (from listener question)
- Don’t trim winners to fund speculative IPOs. Tax bill on a 10-bagger can be brutal. “Water the flowers, pull the weeds” (Buffett/Lynch).
- Use fresh capital, not rotation. Both hosts prefer deploying new cash for new positions rather than selling existing ones.
- Start small, scale in. Matt’s approach: tiny initial position post-IPO, then build incrementally as the hype settles and the market figures out fair value.
- Beware of “diversifying your AI trade.” Selling one AI bet to buy another AI bet is not diversification.
- Watch for liquidity-vacuum effects. Mega-IPOs (OpenAI, SpaceX when they come) can cause institutional rotation out of smaller AI/software names to make room — temporary selling pressure that doesn’t change long-term fundamentals of quality businesses you already own.
- Look for: contract execution, profitability, customer diversification, valuation moderation. Specifically for Cerebras — backlog converting to recognized revenue and concentration dropping below 86%.
Chapter Summaries
- Monday.com Earnings Reaction. Strong beat, raised guidance, RPO and enterprise growth solid, AI now driving 10% of new ARR. But growth still decelerating and GAAP losses persist. Narrative shifted from “AI victim” to “potential AI beneficiary” — hosts encouraged but not buying.
- Cerebras IPO Preview. Wafer-scale chips, OpenAI and AWS deals, 76% revenue growth, but 86% UAE customer concentration and ~100x sales valuation. Hosts will watch from afar.
- Listener Mailbag — Trimming vs. Fresh Capital for IPOs. Use fresh money, start small, wait out hype, mind taxes, and remember mega-IPOs can rotate capital out of smaller related names temporarily.